Related Experiment Video
Updated: Jun 12, 2026

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
Morphology of the subgenual prefrontal cortex in pediatric bipolar disorder
Hasan A Baloch1, John P Hatch, Rene L Olvera
1CERT-BD, Department of Psychiatry, The University of North Carolina at Chapel Hill, 10614 Neurosciences Hospital, Campus Box 7160, Chapel Hill, NC 27599-7160, USA. Baloch@med.unc.edu
Insights
Pediatric bipolar disorder (PBD) patients with a family history of mood disorders may have smaller left subgenual prefrontal cortex (SGPFC) volumes. Mood stabilizers may influence SGPFC size in PBD.
Area of Science:
- Neuroscience
- Psychiatry
- Neuroimaging
Background:
- The subgenual prefrontal cortex (SGPFC) is crucial for emotional regulation and reward processing.
- Volumetric abnormalities in the SGPFC are noted in adult bipolar disorder but not well-studied in pediatric cases.
- Pediatric bipolar disorder (PBD) requires further investigation into SGPFC structural differences.
Purpose of the Study:
- To investigate SGPFC gray matter volumes in children and adolescents with PBD compared to healthy controls.
- To explore the influence of family history of affective disorders and medication status on SGPFC volumes in PBD.
Main Methods:
- Structural MRI scans (1.5 T) were acquired for 51 PBD subjects and 41 healthy controls (HC).
- Manual tracing was used to determine SGPFC gray matter volumes.
- Analysis of covariance (ANCOVA) controlled for age, gender, and intracranial volume.
Main Results:
- No significant overall difference in SGPFC volume was found between PBD and HC subjects.
- PBD subjects with a positive family history of mood disorders showed significantly smaller left SGPFC volumes than HC (p=0.03).
- Mood stabilizer use in PBD was associated with larger right SGPFC volume (p=0.03).
Conclusions:
- A smaller left SGPFC volume may be present in pediatric bipolar disorder patients with a strong family history of mood disorders.
- Mood-stabilizing medication might affect SGPFC volume, potentially masking underlying differences.
- These findings highlight the need to consider genetic vulnerability and medication effects in PBD neuroimaging studies.
Objectives:
The subgenual prefrontal cortex (SGPFC) is an important brain region involved in emotional regulation and reward mechanisms. Volumetric abnormalities in this region have been identified in adults with bipolar disorder but thus far not in pediatric cases. We examined the volume of this brain region in subjects with pediatric bipolar disorder (PBD) and compared them to healthy controls.
Methods:
Fifty one children and adolescents (mean age ± SD; 13.2 ± 2.9 y) with DSM-IV PBD and 41 (mean age ± SD; 13.7 ± 2.7 y) healthy comparison subjects (HC) underwent 1.5 T structural magnetic resonance imaging (MRI) brain scans. We traced the SGPFC manually and compared SGPFC gray matter volumes using analysis of covariance with age, gender, and intracranial volume as covariates. We also examined the relationship of family history of affective disorders and medication status to SGPFC volumes.
Results:
SGPFC volumes were not significantly different in PBD and HC subjects. However, exploratory analysis showed PBD subjects who had one or more first degree relatives with mood disorders (n = 33) had significantly smaller left hemisphere SGPFC compared to HC (p = 0.03 Sidak corrected). Current usage of a mood stabilizer was significantly associated with larger right SGPFC volume in PBD (F = 4.82, df = 1/41, p = 0.03).
Conclusion:
Subjects with PBD and a close family history of mood disorders may have smaller left SGPFC volumes than HC. Mood stabilizing medication may also impact SGPFC size and could have masked more subtle abnormalities overall.
More Related Videos
06:26Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images (SDM-PSI)
Published on: November 27, 2019
13:08Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia
Published on: December 2, 2015
Related Concept Videos
Bipolar Disorder
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Functional Brain Systems: Limbic System